European Shorting
To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2013-05-01 | Sell | 6,000 | $10.09 | 60.5 | -22.3 | 0.00 | 0.00 | 422.454 |  Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2013-04-26 | Sell | 15,000 | $10.72 | 160.8 | -26.87 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LANPHIER EDWARD O II | President & CEO (Click for the stocks that their CEOs have bought) | 2013-04-16 | Sell | 5,190 | $10 | 51.9 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Wolff Henry Ward | Exec VP & CFO | 2013-04-10 | Sell | 10,000 | $10 | 100 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2013-04-01 | Sell | 6,000 | $9.54 | 57.2 | -17.82 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2013-03-26 | Sell | 15,000 | $9.18 | 137.7 | -14.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LANPHIER EDWARD O II | President & CEO | 2013-02-28 | Sell | 25,000 | $10 | 250 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Wolff Henry Ward | Exec VP & CFO | 2013-02-28 | Sell | 10,000 | $10 | 100 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2013-03-01 | Sell | 6,000 | $10 | 60 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2013-01-28 | Sell | 15,000 | $9.68 | 145.2 | -19.01 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2013-02-26 | Sell | 15,000 | $8.64 | 129.6 | -9.26 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2013-02-01 | Sell | 6,000 | $9.53 | 57.2 | -17.73 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-01-28 | Sell | 15,000 | $9.68 | 145.2 | -19.01 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LANPHIER EDWARD O II | President & CEO | 2013-01-24 | Sell | 8,600 | $10 | 86 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Wolff Henry Ward | Exec VP & CFO | 2013-01-23 | Sell | 10,000 | $10 | 100 | -21.6 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2013-01-02 | Sell | 6,000 | $6.05 | 36.3 | 29.59 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-12-26 | Sell | 17,000 | $5.92 | 100.6 | 32.43 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | Vice President, Research & CSO | 2012-12-10 | Sell | 24,000 | $5.46 | 131 | 43.59 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LARSON JOHN WILLIAM | Director | 2012-12-03 | Sell | 15,000 | $5.64 | 84.6 | 39.01 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-11-27 | Sell | 19,736 | $5.53 | 109.1 | 41.77 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LARSON JOHN WILLIAM | Director | 2012-11-01 | Sell | 15,000 | $5.52 | 82.8 | 42.03 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-10-26 | Sell | 20,000 | $5.7 | 114 | 37.54 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | Gregory Philip D | VP, Therapeutic Dev. & CMO | 2012-10-17 | Sell | 6,000 | $6 | 36 | 30.67 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-10-15 | Sell | 5,000 | $5.66 | 28.3 | 38.52 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LARSON JOHN WILLIAM | Director | 2012-10-01 | Sell | 15,000 | $6.2 | 93 | 26.45 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LARSON JOHN WILLIAM | Director | 2012-09-04 | Sell | 15,000 | $5.3 | 79.5 | 47.92 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-09-05 | Sell | 15,000 | $5.6 | 84 | 40 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-08-27 | Sell | 5,000 | $5.18 | 25.9 | 51.35 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | LARSON JOHN WILLIAM | Director | 2012-08-01 | Sell | 15,000 | $5.25 | 78.8 | 49.33 | 0.00 | 0.00 | 422.454 | Link |
| SGMO | Sangamo BioScie... | ANDO DALE G | VP, Therapeutic Dev. & CMO | 2012-07-27 | Sell | 20,000 | $5.47 | 109.4 | 43.33 | 0.00 | 0.00 | 422.454 | Link |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Jean-Marie Eveillard | 2013-03-31 | 300,000 | 0.01% | New Buy | |
| Jim Simons | 2013-03-31 | 209,900 | 0% | New Buy | |
 Most recent portfolio changes are included for Premium Members only!
| |||||
Feedback
My Portfolios
Browse Gurus
Insider Trade Rss Update
Bookmark
This page has been successfully added into your 
RSS
Add Notes, Comments or Ask Questions
Comments